Meeting
2020 ASCO Virtual Scientific Program
Multimodal fluorescence-guided surgery of colorectal peritoneal metastases, a phase I/II clinical trial.
Authors
Jan-Marie de Gooyer
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Jan-Marie de Gooyer , Fortuné Elekonawo , Andre J.A. Bremers , Otto Boerman , Mark Rijpkema , Johannes H.W. de Wilt
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Clinical Trial Registration Number
NCT03699332
Citation
J Clin Oncol 38: 2020 (suppl; abstr TPS4119)
DOI
10.1200/JCO.2020.38.15_suppl.TPS4119
Abstract #
TPS4119
Poster Bd #
111
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Phase Ib/IIa trial of CEND‐1 in combination with neoadjuvant FOLFIRINOX-based therapies in pancreatic, colorectal, and appendiceal cancers (CENDIFOX).
First Author: Anup Kasi
Poster
2018 Gastrointestinal Cancers Symposium
ISO-CC-005: A phase I/II study of Modufolin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer.
First Author: Helena Anna Taflin
Poster
2014 ASCO Annual Meeting
Phase II trial of panitumumab plus FOLFOX4 or FOLFIRI in subjects with KRAS wild-type colorectal cancer and liver-limited disease: The PLANET study.
First Author: Albert Abad
Poster
2011 ASCO Annual Meeting
Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls.
First Author: M. Morse